ArticleHypertension research : official journal of the Japanese Society of Hypertension2025
Prevention of atherosclerotic cerebro-cardiovascular disease: a key objective in blood pressure management for coronary artery disease in East Asia.
Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association of Ambulatory Arterial Pressure Index with Circadian Blood Pressure Patterns in Patients with Primary Hypertension and Coronary Artery Disease.International journal of general medicine · 2026Article
- Practice and Effect Evaluation of Hypertension Homogenization Management Model Under the "Walking Hospital" Mode in Primary Medical Institutions.International journal of general medicine · 2025Article
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Atherosclerotic cerebro-cardiovascular disease is multi-vascular and multi-organ disease resulting from both chronic and acute risk factors. BP, blood pressure; ACS, acute coronary syndrome, CCS, chronic coronary syndrome; HFrEF, heart failure with reduced ejection fraction; HFpEF heart failure with preserved ejection fraction, PAD peripheral artery disease, CKD chronic kidney disease, RF renal failure.
Indexed as
Identifiers
39478192What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.